Immunoglobulin

Pune, India, July 13, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on “Plasma Fractionation Market Revenue Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, End User, and…

Pune, India, June 05, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global Immunoglobulin Market size was valued at USD 15.05 billion in 2022 and is projected to grow from 16.24 billion in 2023 to USD 29.57 billion by…

<!-- Name:DistributionId Value:8793501 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2791 -->…

<!-- Name:DistributionId Value:8746136 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5557 -->…

Kajian INDIGO Fasa Global 3 akan menilai keberkesanan dan keselamatan obexelimab dalam kalangan pesakit yang menghidap IgG4-RD, penyakit fibroinflamasi kronik dan serius yang biasanya menjejaskan pelbagai organ IgG4-RD adalah yang…

Pune, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Global Immunoglobulin Market is expected to clock US$ 23.1 billion by 2030, according to the latest report published by Growth Plus Reports. The global immunoglobulin market has been…

New York, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (IgG, IgA, IgM, IgE, and IgD),…

Portland, OR, July 07, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Downstream Processing Market was estimated at $21.8 billion in 2020 and is expected to hit $92.0 billion by 2030,…

A clinical trial has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, is not more effective than remdesivir alone for treating adults…

NIAID has initiated a Phase 3 clinical trial to evaluate the efficacy and safety of hyperimmune globulin products, including Emergent’s COVID-19 Human Immune Globulin (COVID-HIG), for potential treatment of COVID-19 in adult patients at…